View |
|
DRP-13487-01
|
Tramadol Hydrochloride
|
Opiodex
|
50 mg
|
Capsule
|
Analgesic (Opioid)
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
10 May 2023
|
27 February 2028
|
View |
|
DRP-11571
|
Clobetasol Propionate
|
Clohab
|
500 mcg/g (0.05% w/w)
|
Ointment
|
Corticosteroid
|
Kolmar Korea Co., Ltd.
|
Korea
|
Initial
|
30 March 2022
|
30 March 2027
|
View |
|
DRP-14373
|
Cilostazol
|
Ciloheme 100
|
100 mg
|
Tablet
|
Antithrombotic Agent (Platelet aggregation inhibitor)
|
Cooper Pharma Limited
|
India
|
Initial
|
30 August 2023
|
30 August 2028
|
View |
|
DRP-14374
|
Cilostazol
|
Ciloheme 50
|
50 mg
|
Tablet
|
Antithrombotic Agent (Platelet aggregation inhibitor)
|
Cooper Pharma Limited
|
India
|
Initial
|
30 August 2023
|
30 August 2028
|
View |
|
DRP-15413
|
Carvedilol
|
Caprel
|
6.25 mg
|
Film-Coated Tablet
|
Alpha and Beta Blocking Agent
|
Baroque Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
05 July 2024
|
05 July 2029
|
View |
|
DRP-15412
|
Clarithromycin
|
Klarithro
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Baroque Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
05 July 2024
|
05 July 2029
|
View |
|
DRHR-2370
|
Ethyl Alcohol
|
Member's Value
|
70 mL per 100 mL (70% v/v)
|
Solution (Star Air Scent)
|
Antiseptic/Disinfectant
|
Kohl Industries Corporation.
|
Philippines
|
Initial [HR]
|
08 July 2024
|
08 July 2029
|
View |
|
DRP-15425
|
Cholecalciferol (Vitamin D3)
|
Lifeciferol
|
200 IU per mL
|
Syrup (Oral Drops) (Orange Flavor)
|
Vitamin
|
Azine Healthcare Pvt., Ltd
|
India
|
Initial [OTC]
|
08 July 2024
|
08 July 2029
|
View |
|
DR-XY49125
|
Tramadol Hydrochloride + Paracetamol
|
Adolpan
|
37.5 mg/325 mg
|
Film-Coated Tablet
|
Opioid in Combination with Non-Opioid Analgesic
|
Pharmix Laboratories (Pvt) Ltd)
|
Pakistan
|
Initial (Reapplication)
|
05 July 2024
|
05 July 2029
|
View |
|
DRP-15411
|
Cytarabine
|
Cytamax 100
|
100 mg/mL
|
Solution for Injection (IV)
|
Antineoplastic Agent (Pyrimidine analogue)
|
United Biotech Pvt. Limited
|
India
|
Initial
|
05 July 2024
|
05 July 2029
|
View |
|
DR-XY49126
|
Dexmedetomidine
|
None
|
100 mcg/mL
|
concentrate solution for IV infusion
|
Hypnotic and Sedative
|
B. Braun Medical, S.A
|
Spain
|
Initial
|
08 July 2024
|
08 July 2029
|
View |
|
DRP-15417
|
Telmisartan
|
Tsartan 40
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Inventia Healthcare Limited
|
India
|
Initial
|
05 July 2024
|
05 July 2029
|
View |
|
DRP-15416
|
Telmisartan
|
Tsartan 80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Inventia Healthcare Limited
|
India
|
Initial
|
05 July 2024
|
05 July 2029
|
View |
|
DRP-15427
|
Clindamycin (as phosphate)
|
Clindavest 600
|
150 mg/mL (600 mg/4 mL)
|
Solution for Injection (IM/IV)
|
Antibacterial (Lincosamide)
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
Initial
|
08 July 2024
|
08 July 2029
|
View |
|
DR-XY49122
|
Telmisartan + Amlodipine (as Besilate)
|
Telmez CCB
|
80 mg/10 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB) & Calcium
Channel Blocker
|
Ajanta Pharma Limited
|
India
|
Initial
|
05 July 2024
|
05 July 2029
|
View |
|
DRP-15431
|
Clobetasol propionate
|
Dermafina
|
500 mcg/mg (0.05% w/w)
|
Topical Cream
|
Corticosteroid
|
Lincoln Pharmaceuticals Ltd.
|
India
|
Initial
|
08 July 2024
|
08 July 2029
|
View |
|
DRP-15428
|
Clindamycin (as phosphate)
|
Clindacare 600
|
150 mg/mL (600 mg/4 mL)
|
Solution for Injection (IM/IV)
|
Antibacterial (Lincosamide)
|
Furen Pharmaceutical Group Co., Ltd..
|
China
|
Initial
|
08 July 2024
|
08 July 2029
|
View |
|
DRP-15415
|
Ketoconazole + Clobetasol Propionate
|
Bellaskin
|
10 mg/500 mcg per gram
|
Cream
|
Antifungal/ Corticosteroid
|
Front Pharmaceutical PLC
|
China
|
Initial
|
05 July 2024
|
05 July 2029
|
View |
|
DRP-15392
|
Vildagliptin + Metformin HCI
|
Alvovilda Met
|
50 mg/850 mg
|
Film-coated Tablet
|
Combination of oral blood glucose lowering drugs
|
Intas Pharmaceuticals Limited.
|
India
|
Initial
|
08 July 2024
|
08 July 2029
|
View |
|
DRP-15391
|
Vildagliptin + Metformin HCI
|
Alvovilda Met
|
50 mg/1 g
|
Film-coated Tablet
|
Combination of oral blood glucose lowering drugs
|
Intas Pharmaceuticals Limited.
|
India
|
Initial
|
08 July 2024
|
08 July 2029
|